Oxygen News and Research

RSS

New single-agent phototherapy system may form valuable new tool to combat cancer

Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.

30 Oct 2015

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

A new study from scientists at The Scripps Research Institute helps explain why cancer metastasis is so hard to stop.

29 Oct 2015

GDF10 molecule identified as a key player in repair mechanisms after stroke

Looking at brain tissue from mice, monkeys and humans, scientists have found that a molecule known as growth and differentiation factor 10 (GDF10) is a key player in repair mechanisms following stroke. The findings suggest that GDF10 may be a potential therapy for recovery after stroke.

29 Oct 2015

New technique may enable in-flight detection of hypoxia in pilots

Researchers working in the United States have demonstrated a technique that may enable real-time, in-flight detection of hypoxia in pilots.

29 Oct 2015

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

For about the last 25 years, the cardiology group here have been developing a platform technology for both the diagnosis and treatment of atherosclerosis.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 28 Oct 2015

New fluorescent dye could serve as powerful tool to visualize biological events in living cells

A new photostable fluorescent dye for super resolution microscopy could serve as a powerful tool to visualize biological events and structural details in living cells at real-time for prolonged recording periods.

27 Oct 2015

Dehaier awarded medical equipment procurement agreement from HAPP Committee

Dehaier Medical Systems Ltd., which develops, markets and sells medical devices and wearable sleep respiratory products in China and international markets, today announced that it has been awarded a medical equipment procurement agreement from China's Health & Anti-Poverty Program Committee ("HAPP Committee").

26 Oct 2015

Nitrous oxide shows promise in patients at risk for cardiovascular disease

Nitrous oxide, an effective and inexpensive anesthetic, is safe for surgical patients who have or are at risk for cardiovascular disease, according to results of a large randomized controlled trial being presented at the ANESTHESIOLOGY 2015 annual meeting.

26 Oct 2015

Potential new drug target for acute myeloid leukemia

New treatment options are badly needed for acute myeloid leukemia, a relatively rare form of cancer. The malignancy begins in the bone marrow, and from there can spread rapidly to the bloodstream, depriving the body of the essential blood cells that carry oxygen and fight infections.

23 Oct 2015

IPF-PRO Registry data sheds light on characteristics of people with idiopathic pulmonary fibrosis

Boehringer Ingelheim Pharmaceutical, Inc. today announced initial results of the first 49 people enrolled in the IPF-PRO Registry, which shed light on characteristics of people with IPF at the time of diagnosis.

23 Oct 2015

Breakthrough research suggests that female sex hormone may save lives on the battlefield

Breakthrough research suggests a female sex hormone may be the key to saving lives on the battlefield, where between 2001 and 2011 more than 80 percent of potentially preventable U.S. war injury deaths resulted from blood loss.

22 Oct 2015

Noninvasive ventilation and supplemental oxygen during exercise training benefit patients with severe COPD

Researchers from Turkey's Ege University Department of Biostatistics evaluated the effects of noninvasive ventilation (NIV) and supplemental oxygen during exercise training (ET) and found it to have multiple physiologic benefits in patients with severe COPD. Results showed that supplemental oxygen during exercise helped to reduce hyperinflation and improve respiratory muscle function and exercise capacity.

20 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

New manganese-based catalyst may accelerate drug discovery, development

Chemists have long believed that inserting nitrogen -- a beneficial ingredient for making many pharmaceuticals and other biologically active molecules -- into a carbon-hydrogen bond requires a trade-off between catalyst reactivity and selectivity.

15 Oct 2015

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

An international research team led by scientists at the University of New Mexico Cancer Center discovered and developed a novel ligand peptide-mimic that inhibits abnormal overgrowth of blood vessels in retinal diseases and tumors. The discovery could lead to new drugs that keep cancers from growing. The team published a paper in the journal Science Translational Medicine.

15 Oct 2015

Forces in external environmental and oxidation are greatest threats to DNA, study finds

A study led by Indiana University biologist Patricia Foster and colleagues has found that forces in the external environment and oxidation are the greatest threats to an organism's ability to repair damage to its own DNA.

14 Oct 2015

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

A team of UCLA scientists has found that brain areas linked to social behaviors are both underdeveloped and insufficiently networked in youths with high functioning autism spectrum disorder (ASD) compared to study participants without ASD.

14 Oct 2015

Danish researchers face possible breakthrough in fight against cancer

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.

13 Oct 2015

Study explains why anemia is a common side effect of anti-cancer drugs

Many types of leukemia are caused by loss of enzymes such as Pten, which normally keeps cell growth in check, or conversely, the over-activation of enzymes that normally enhance cell proliferation, such as Shp2.

13 Oct 2015

Pregnant women with elevated blood-sugar levels more likely to have babies with heart defects

Pregnant women with elevated blood-sugar levels are more likely to have babies with congenital heart defects, even if their blood sugar is below the cutoff for diabetes, according to a new study from the Stanford University School of Medicine and Stanford Children's Health.

12 Oct 2015

Oxygen News and Research

New single-agent phototherapy system may form valuable new tool to combat cancer

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

GDF10 molecule identified as a key player in repair mechanisms after stroke

New technique may enable in-flight detection of hypoxia in pilots

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

New fluorescent dye could serve as powerful tool to visualize biological events in living cells

Dehaier awarded medical equipment procurement agreement from HAPP Committee

Nitrous oxide shows promise in patients at risk for cardiovascular disease

Potential new drug target for acute myeloid leukemia

IPF-PRO Registry data sheds light on characteristics of people with idiopathic pulmonary fibrosis

Breakthrough research suggests that female sex hormone may save lives on the battlefield

Noninvasive ventilation and supplemental oxygen during exercise training benefit patients with severe COPD

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

New manganese-based catalyst may accelerate drug discovery, development

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

Forces in external environmental and oxidation are greatest threats to DNA, study finds

Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD

Danish researchers face possible breakthrough in fight against cancer

Study explains why anemia is a common side effect of anti-cancer drugs

Pregnant women with elevated blood-sugar levels more likely to have babies with heart defects

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC